Sharon Benzeno, Chief Business Development Officer at Adaptive Biotechnologies Corp (ADPT), sold 12,649 shares at $48.46 ($614K) on 2020-10-01, disclosed to the SEC on 2020-10-02.
Open-market sale of $614k ADPT by Chief Business Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.46 | 5,878 | $285K | 46.4% |
| 2 | $48.46 | 5,878 | $285K | 46.4% |
| 3 | $49.26 | 893 | $44K | 7.2% |
| Total | $48.52 avg | 12,649 | $614K | 100% |
| Filing → |
| ADPT | SELL | 2025-12-08 | $425K | — | Filing → |
| ADPT | SELL | 2025-11-24 | $20.3M | — | Filing → |
| ADPT | SELL | 2025-03-06 | $312K | — | Filing → |